CDSCO panel eases approval steps for generic lenacapavir
Indian drugmakers are moving closer to launching affordable generic lenacapavir after a CDSCO regulatory panel recommended waiving local late-stage clinical trials.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.